Primary aldosteronism
Authors:
- Vin-Cent WuVWVin-Cent Wu
- Chin-Chi KuoCKChin-Chi Kuo
- Shuo-Meng WangSWShuo-Meng Wang
- Kao-Lang LiuKLKao-Lang Liu
- Kuo-How HuangKHKuo-How Huang
- Yen-Hung LinYLYen-Hung Lin
- Tzong-Shinn ChuTCTzong-Shinn Chu
- Hung-Wei ChangHCHung-Wei Chang
- Chien-Yu LinCLChien-Yu Lin
- Chia-Ti TsaiChia-Ti Tsai
- Lian-Yu LinLLLian-Yu Lin
- Shih-Chieh ChuehSCShih-Chieh Chueh
- 1 September 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 29 (9) , 1778-1786
Abstract
To obtain information about the effect of prolonged aldosterone excess on kidney function. We determined kidney function changes defined by cystatin C-based estimations of glomerular filtration rate (CysC-GFR). Pretreatment proteinuria and intrarenal Doppler velocimetric indices in primary aldosteronism were examined and followed after adrenalectomy or spironolactone treatment. This prospective, multicenter study included 130 primary aldosteronism patients (56 men; age, 49.9 ± 13.4 years: 100 with adenoma and 30 with idiopathic hyperaldosteronism) and 73 essential hypertension patients (36 men; age, 51.4 ± 14.8 years) as controls. Patients with primary aldosteronism had higher CysC-GFR (P < 0.05) and heavier proteinuria (0.042) than those with essential hypertension. With primary aldosteronism, a higher aldosterone-renin ratio (odds ratio, OR = 7.85, P = 0.008) was independently related to pretreatment CysC-GFR. The factors related to pretreatment proteinuria included CysC-GFR (OR, -0.006, P = 0.001), plasma aldosterone concentration (OR, 0.004, P = 0.002), and duration of hypertension (OR, 0.016, P = 0.032). Duration of hypertension was also independently correlated with the pretreatment resistive index among primary aldosteronism patients (OR, 0.004, P = 0.035). CysC-GFR (all, P < 0.05), proteinuria (P < 0.001), and resistive index (P < 0.001) decreased 1 year after adrenalectomy but not with spironolactone treatment. Our data suggest that prolonged hyperaldosteronism will cause relative kidney hyperfiltration and reversible intrarenal vascular structural changes, which disguise the consequent renal injury, including declining GFR and proteinuria. Adrenalectomy and spironolactone treatment exert different clinical impacts toward kidney damage even with a similar blood pressure-lowering effect.Keywords
This publication has 42 references indexed in Scilit:
- Mitochondrial Dysfunction Mediates Aldosterone-Induced Podocyte DamageThe American Journal of Pathology, 2011
- Hyperfiltration Affects Accuracy of Creatinine eGFR MeasurementClinical Journal of the American Society of Nephrology, 2011
- Disparate effects of eplerenone, amlodipine and telmisartan on podocyte injury in aldosterone-infused ratsNephrology Dialysis Transplantation, 2010
- Kidney function estimated from serum creatinine and cystatin C and peripheral arterial disease in NHANES 1999-2002European Heart Journal, 2009
- Cystatin C Associates with Arterial Stiffness in Older AdultsJournal of the American Society of Nephrology, 2009
- Mineralocorticoid receptor antagonism attenuates glomerular filtration barrier remodeling in the transgenic Ren2 ratAmerican Journal of Physiology-Renal Physiology, 2009
- Intrarenal Hemodynamics in Primary Aldosteronism before and after TreatmentThe Journal of Clinical Endocrinology & Metabolism, 2009
- Serial Measurements of Cystatin C Are More Accurate Than Creatinine-Based Methods in Detecting Declining Renal Function in Type 1 DiabetesDiabetes Care, 2008
- Estimating GFR Using Serum Cystatin C Alone and in Combination With Serum Creatinine: A Pooled Analysis of 3,418 Individuals With CKDAmerican Journal of Kidney Diseases, 2008
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976